Literature DB >> 17704986

[Herb-drugs interactions].

Johannes Freudenstein1, Thomas Nisslein.   

Abstract

Herbal therapeutics are increasingly associated with herb drug interactions. The vast majority of the purported cases is unsubstantiated and misinterpreted. Pharmacological and clinical studies should only be demanded in cases of reliable evidence. First steps to be taken by manufacturers of herbal drugs should be in vitro studies with metabolizing systems like CYP and P-gp. Manufacturers of drugs that are metabolized by modulated systems should be requested to conduct drug specific interaction studies as necessary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704986     DOI: 10.1007/s10354-007-0438-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  15 in total

1.  St. John's wort and antidepressant drug interactions in the elderly.

Authors:  M S Lantz; E Buchalter; V Giambanco
Journal:  J Geriatr Psychiatry Neurol       Date:  1999       Impact factor: 2.680

Review 2.  Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.

Authors:  K Venkatakrishnan; L L Von Moltke; D J Greenblatt
Journal:  J Clin Pharmacol       Date:  2001-11       Impact factor: 3.126

Review 3.  Systematic overview of drug interactions with antidepressant medications.

Authors:  Carmine Nieuwstraten; N Renee Labiris; Anne Holbrook
Journal:  Can J Psychiatry       Date:  2006-04       Impact factor: 4.356

4.  Drug interaction between St. John's wort and cyclosporine.

Authors:  G W Barone; B J Gurley; B L Ketel; M L Lightfoot; S R Abul-Ezz
Journal:  Ann Pharmacother       Date:  2000-09       Impact factor: 3.154

5.  Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin.

Authors:  I Mai; H Krüger; K Budde; A Johne; J Brockmöller; H H Neumayer; I Roots
Journal:  Int J Clin Pharmacol Ther       Date:  2000-10       Impact factor: 1.366

Review 6.  Drug-herb interactions: eliminating toxicity with hard drug design.

Authors:  Xiao-Xia Yang; Ze-Ping Hu; Wei Duan; Yi-Zhun Zhu; Shu-Feng Zhou
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 7.  Pharmacokinetic herb-drug interactions: are preventive screenings necessary and appropriate?

Authors:  Veronika Butterweck; Hartmut Derendorf; Wilhelm Gaus; Adolf Nahrstedt; Volker Schulz; Matthias Unger
Journal:  Planta Med       Date:  2004-09       Impact factor: 3.352

8.  An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies.

Authors:  J Strandell; A Neil; G Carlin
Journal:  Phytomedicine       Date:  2004-02       Impact factor: 5.340

Review 9.  [Clinical-pharmacological aspects to accelerate the development process from the preclinical to the clinical phase/2nd communication: promising strategies].

Authors:  Jochen Kuhlmann
Journal:  Arzneimittelforschung       Date:  2004

10.  The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.

Authors:  S M Rajah; A F Penny; M J Crow; M D Pepper; D A Watson
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.